Thomas Jefferson University

Lisa Maslankowski

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kasaro MP, Husnik MJ, Chi BH, Reid C, Magure T, Makanani B, Tembo T, Ramjee G, Maslankowski L, Rabe L, Brad Guffey M. Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study. Int J STD AIDS. 2017 04; 28(5):467-475. PMID: 27277555.
      Citations:    
    2. Gorbach PM, Kelly CW, Borgerding JA, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L. Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035). AIDS Behav. 2014 May; 18(5):855-61. PMID: 24158488.
      Citations:    
    3. Chirenje ZM, M?sse BR, Maslankowski LA, Ramjee G, Coletti AS, Tembo TN, Magure TM, Soto-Torres L, Kelly C, Hillier S, Karim A. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. J Int AIDS Soc. 2012 Aug 27; 15(2):17376. PMID: 22944480.
      Citations:    
    4. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, M?sse B, Hillier SL, Soto-Torres L. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011 Apr 24; 25(7):957-66. PMID: 21330907.
      Citations:    
    5. Schreiber CA, Whittington S, Cen L, Maslankowski L. Good intentions: risk factors for unintended pregnancies in the US cohort of a microbicide trial. Contraception. 2011 Jan; 83(1):74-81. PMID: 21134507.
      Citations:    
    6. Rosen RK, Morrow KM, Carballo-Di?guez A, Mantell JE, Hoffman S, Gai F, Maslankowski L, El-Sadr WM, Mayer KH. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt). 2008 Apr; 17(3):383-92. PMID: 18328009.
      Citations:    
    7. Carballo-Di?guez A, Bal?n IC, Morrow K, Rosen R, Mantell JE, Gai F, Hoffman S, Maslankowski L, El-Sadr W, Mayer K. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). AIDS Care. 2007 Sep; 19(8):1026-31. PMID: 17852000.
      Citations:    
    8. El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, Mauck C, Absalon J, Morrow K, M?sse B, Soto-Torres L, Kwiecien A. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS. 2006 May 12; 20(8):1109-16. PMID: 16691061.
      Citations:    
    9. Joshi S, Dutta S, Bell B, Profy A, Kuruc J, Fang G, Cianciola M, Maslankowski L, Soto-Torres L, Panchanadikar A, Mehendale S, Reynolds SJ. Documenting intermenstrual bleeding in a vaginal microbicide study: case reports and lessons learned. AIDS Res Hum Retroviruses. 2006 Mar; 22(3):294-6. PMID: 16545017.
      Citations:    
    10. Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, M?sse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006 Feb 28; 20(4):543-51. PMID: 16470118.
      Citations:    
    11. Njoroge B, Chirenje ZM, Pandey B, Mirembe F, Joshi S, Low-Beer N, Maslankowski LA. The CONRAD/WHO Update 2000 colposcopy manual: how well is it working? J Acquir Immune Defic Syndr. 2004 Oct; 37 Suppl 3:S150-1. PMID: 16419263.
      Citations:    
    12. Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. J Womens Health (Larchmt). 2003 Sep; 12(7):655-66. PMID: 14583106.
      Citations:    
    13. Mayer KH, Karim SA, Kelly C, Maslankowski L, Rees H, Profy AT, Day J, Welch J, Rosenberg Z. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 2003 Feb 14; 17(3):321-9. PMID: 12556685.
      Citations:    
    14. Mintz ED, Effler PV, Maslankowski L, Ansdell V, Pon E, Barrett TJ, Tauxe RV. A rapid public health response to a cryptic outbreak of cholera in Hawaii. Am J Public Health. 1994 Dec; 84(12):1988-91. PMID: 7998643.
      Citations:    
    Maslankowski's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (76)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _